The 2022 EULAR/ACR Points to Consider at the Early Stages of Diagnosis and Management of Suspected Haemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS)

Shakoory, B.; Geerlinks, A.; Wilejto, M.; Kernan, K.; Hines, M.; Romano, M.; Piskin, D.; Ravelli, A.; Sinha, R.; Aletaha, D.; E. Allen, Carl; Bassiri, H.; Behrens, E.; A. Carcillo, Joseph; Carl, Linda; Chatham, W.; Cohen, J.; Cron, R.; Drewniak, Erik; Grom, A.; A Henderson, Lauren; Horne, A.; Jordan, M.; E. Nichols, Kim; Schulert, G.; Vastert, S.; Demirkaya, E.; Goldbach-Mansky, R.; de Benedetti, Fabrizio; Marsh, R.; Canna, S.

doi:10.1002/art.42636

Public

The 2022 EULAR/ACR Points to Consider at the Early Stages of Diagnosis and Management of Suspected Haemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS)

Shared by NobleBlocks on Jul 24, 2023 • 12:00 AM UTC

Authors:

B. Shakoory

A. Geerlinks

M. Wilejto

Abstract

Haemophagocytic lymphohistiocytosis (HLH) and macrophage activation syndrome (MAS) are life‐threatening systemic hyperinflammatory syndromes that can develop in most inflammatory contexts. They can progress rapidly, and early identification and management are critical for preventing organ failure an...

Subject

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!